Intrinsic Value of S&P & Nasdaq Contact Us

SciClone Pharmaceuticals, Inc. SCLN NASDAQ

NASDAQ • Healthcare • Drug Manufacturers - Specialty & Generic • USD

SharesGrow Score
80/100
5/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

SciClone Pharmaceuticals, Inc. (SCLN) has 11 known insider and institutional holders on record. The largest holder is CAVAZZA PAOLO with 6,580,938 shares. Other notable holders include Sinaf S.A. and Ally Bridge LB Healthcare Master Fund Ltd.

SCLN Insider Ownership

Top Holder
CAVAZZA PAOLO
6,580,938 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Cavazza Paolo 10 Percent Owner 6,580,938 2008-02-01
100%
2 Sinaf S.a. Other: Member of 10% Owner Group 1,289,052 2010-07-01
20%
3 Ally Bridge Lb Healthcare Master Fund Ltd Other: Member of 10% Owner Group 678,077 2016-03-01
10%
4 Wong Stephanie VP, Finance and Controller 50,000 2013-04-08
1%
5 Titus Gary Senior VP Finance & CFO 37,095 2012-06-18
1%
6 Lapointe Anthony Gregg Other: Board Member 30,000 2017-06-09
0%
7 Woodman Dean S Director 30,000 2010-06-14
0%
8 Chang Nancy T Other: Board Member 30,000 2017-06-09
0%
9 Hawkins Richard J Other: Board Member 30,000 2017-06-09
0%
10 Cheung Wilson Wai-shun CFO & Senior VP, Finance 17,158 2017-08-16
0%
11 Lapointe Gregg Anthony Director 5,000 2009-06-11
0%

No ownership data available for SCLN.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message